Treatment effectiveness of high-risk neuroblastoma is improved with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13- cis -retinoic acid

High Risk ◽

Marrow Transplantation ◽

Treatment Effectiveness ◽

Autologous Bone Marrow ◽

Intensive Chemotherapy ◽

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

New England Journal of Medicine ◽

10.1056/nejm199910143411601 ◽

1999 ◽

Vol 341 (16) ◽

pp. 1165-1173 ◽

Cited By ~ 1312

Author(s):

Katherine K. Matthay ◽

Judith G. Villablanca ◽

Robert C. Seeger ◽

Daniel O. Stram ◽

Richard E. Harris ◽

...

Keyword(s):

Bone Marrow ◽

Retinoic Acid ◽

High Risk ◽

Marrow Transplantation ◽

Autologous Bone Marrow ◽

Intensive Chemotherapy ◽

#506 Improved disease-free survival in children with high-risk all following autologous bone marrow transplantation (ABMT) that utilizes chemopurging post ABMT modulation of multidirug resistance (MDR) and immunochemotherapy

Journal of Pediatric Hematology/Oncology ◽

10.1097/00043426-199907000-00133 ◽

1999 ◽

Vol 21 (4) ◽

pp. 337

Author(s):

I. Houtenbos ◽

F. Bracho ◽

V. Davenport ◽

R. Slack ◽

C. Van de Ven ◽

...

Keyword(s):

Bone Marrow ◽

High Risk ◽

Marrow Transplantation ◽

Disease Free Survival ◽

Autologous Bone Marrow ◽

Free Survival ◽

Autologous Bone ◽

Disease Free

Intensive chemotherapy with autologous bone marrow transplantation in patients with locally advanced breast cancer: 12-years follow-u

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.700 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 700-700

Author(s):

A. Reyners ◽

H. Hollema ◽

N. Mulder

Keyword(s):

Breast Cancer ◽

Bone Marrow ◽

Marrow Transplantation ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Autologous Bone Marrow ◽

Intensive Chemotherapy ◽

Intensive chemotherapy with autologous bone marrow transplantation for advanced lung cancer

Lung Cancer ◽

10.1016/0169-5002(96)85924-1 ◽

1996 ◽

Vol 14 (1) ◽

pp. 169

Keyword(s):

Lung Cancer ◽

Bone Marrow ◽

Marrow Transplantation ◽

Autologous Bone Marrow ◽

Advanced Lung Cancer ◽

Intensive Chemotherapy ◽

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00273421 ◽

1988 ◽

Vol 22 (3) ◽

pp. 256-262 ◽

Cited By ~ 34

Author(s):

M. H. Gaspard ◽

D. Maraninchi ◽

A. M. Stoppa ◽

J. A. Gastaut ◽

G. Michel ◽

...

Keyword(s):

Bone Marrow ◽

Antitumor Activity ◽

Cytosine Arabinoside ◽

Marrow Transplantation ◽

Autologous Bone Marrow ◽

Intensive Chemotherapy ◽

Autologous Bone ◽

High Doses

Treatment of High-Risk Solid Tumors of Childhood with Intensive Therapy and Autologous Bone Marrow Transplantation

Pediatric Clinics of North America ◽

10.1016/s0031-3955(16)38084-1 ◽

1991 ◽

Vol 38 (2) ◽

pp. 393-424 ◽

Cited By ~ 37

Author(s):

Robert C. Seeger ◽

C. Patrick Reynolds

Keyword(s):

Bone Marrow ◽

High Risk ◽

Solid Tumors ◽

Marrow Transplantation ◽

Intensive Therapy ◽

Autologous Bone Marrow ◽

Rationale of intensive chemotherapy associated with autologous bone marrow transplantation

Revue Fran&#xE7 aise de Transfusion et Immuno-h&#xE9 matologie ◽

10.1016/s0338-4535(85)80012-x ◽

1985 ◽

Vol 28 (5) ◽

pp. 373-382

Author(s):

R ZITTOUN

Keyword(s):

Bone Marrow ◽

Marrow Transplantation ◽

Autologous Bone Marrow ◽

Intensive Chemotherapy ◽

13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma

Medical and Pediatric Oncology ◽

10.1002/(sici)1096-911x(199904)32:4<308::aid-mpo14>3.0.co;2-f ◽

1999 ◽

Vol 32 (4) ◽

pp. 308-310 ◽

Cited By ~ 1

Author(s):

Barbara A. Degar ◽

Robert D. Harrington ◽

Joel M. Rappeport ◽

Ann E. Woolfrey

Keyword(s):

Bone Marrow ◽

Retinoic Acid ◽

Marrow Transplantation ◽

Autologous Bone Marrow ◽

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

The Lancet ◽

10.1016/s0140-6736(97)09214-3 ◽

1998 ◽

Vol 351 (9104) ◽

pp. 700-708 ◽

Cited By ~ 414

Author(s):

Alan K Burnett ◽

Anthony H Goldstone ◽

Richard MF Stevens ◽

Ian M Hann ◽

John KH Rees ◽

...

Keyword(s):

Bone Marrow ◽

Acute Myeloid Leukaemia ◽

Marrow Transplantation ◽

Autologous Bone Marrow ◽

Intensive Chemotherapy ◽

First Remission ◽

Autologous Bone ◽

Acute Myeloid

Phase I/II Trial with Low-Dose Interleukin-2 and Interferon-Gamma in Children with High-Risk Leukemia and Non-Hodgkin’s Lymphoma After Autologous Bone Marrow Transplantation

Cytokines in Hemopoiesis, Oncology, and AIDS II ◽

10.1007/978-3-642-48715-6_98 ◽

1992 ◽

pp. 775-782 ◽

Cited By ~ 1

Author(s):

E. Baumgarten ◽

H. Schmid ◽

U. Pohl ◽

J. Kühl ◽

H. J. Spaar ◽

...

Keyword(s):

Bone Marrow ◽

High Risk ◽

Phase I ◽

Interferon Gamma ◽

Marrow Transplantation ◽

Interleukin 2 ◽

Autologous Bone Marrow ◽